“G-Protein Coupled Receptors (GPCRs): A Potential Target of Apigenin As a Novel HACE2 Receptor Specific Therapeutic for Impeding Lung Cancer Considering a Group of Missense and Nonsense Mutations in COVID-19 Patients”. European Journal of Pharmaceutical Research, vol. 5, no. 1, May 2025, pp. 6-15, https://doi.org/10.24018/ejpharma.2025.5.1.85.